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 Abstract 
 
Dysfunction in cholesterol storage and transport contributes to various 
different diseases such as Niemann Pick C Disease, congenital adrenal 
hyperplasia or foam cell formation in atherosclerosis. Cholesterol plays an 
important role in adrenals and ovaries where it serves as the basis for the 
synthesis of steroid hormones. 
Intracellular cholesterol is stored in lipid droplets. However, it needs to be 
transported into the mitochondrial matrix to be converted into 
pregnenolone as the first step of steroidogenesis. While a protein complex 
consisting of the so called transduceosome and metabolon has been 
identified to mediate cholesterol transport across the outer and inner 
mitochondrial membrane respectively, the transportation mechanism of 
cholesterol from lipid droplets to the outer mitochondrial membrane is still 
elusive. As SNARE proteins (soluble N-ethylmaleimide-sensitive-factor 
attachment receptor proteins) can mediate vesicular transport and have 
been found on lipid droplets, it was the aim of this study to investigate if 
cholesterol is transported from lipid droplets to mitochondria in a SNARE-
mediated manner.  
 
Mitochondria were isolated from rat ovaries and adrenals. In an in-vitro 
reconstitution bioassay, various combinations of purified recombinant His-
tagged SNAREs (SNAP23, SNAP25, NSF, α-SNAP and Stx17) were added 
to mitochondria and cholesterol lipid droplets. It was analysed via ELISA 
how much pregnenolone was synthesised from the cholesterol added in 
the form of lipid droplets. The more cholesterol is transported into the 
mitochondrial matrix, the more pregnenolone can be produced. 
Furthermore, the effect of GTP (guanosine triphosphate) and cytosol on 
pregnenolone production was investigated.  
 
Addition of SNARE proteins resulted in a 46fold increase in pregnenolone 
production (p<0.0001, Tukey’s multiple comparison test), indicating their 
 
 
 involvement in cholesterol transport from lipid droplets to mitochondria. In 
particular, the combination of SNAP23, SNAP25, NSF and α-SNAP was 
found to mediate cholesterol transport to the outer mitochondrial 
membrane (p<0.05, Sidak’s Multiple Comparison Test) while the detailed 
role of Stx17 remains unclear. Furthermore, it was observed that cytosolic 
components enhance SNARE-mediated cholesterol transport without need 
for GTP (p<0.05, Sidak’s Multiple Comparison Test).  
 
Overall, these results allow proposing a model of SNARE-mediated 
cholesterol transport from lipid droplets to the outer mitochondrial 
membrane and across the mitochondrial membranes into the matrix for 
steroidogenesis. Cholesterol might join the cholesterol pool in the outer 
mitochondrial membrane by hemifusion of lipid droplets with the outer 
mitochondrial membrane. StAR (steroidogenesis acute regulatory protein) 
could bind cholesterol from this cholesterol pool before it induces its 
transport across the mitochondrial membranes via the 
transduceosome/metabolon. Cholesterol is then converted into 
pregnenolone as the first step of steroidogenesis in the mitochondrial 
matrix.  
 
This study sheds new light on transportation of cholesterol from lipid 
droplets to the outer mitochondrial membrane in vitro. Incorporating the 
results into previous findings, a model of SNARE mediated cholesterol 
transport from lipid droplets into the mitochondrial matrix for 
steroidogenesis is proposed. The exact molecular mechanism of SNARE 
mediated cholesterol transport and the detailed role of each SNARE within 
this process in vivo remain to be determined.  
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 1 Introduction  
1.1 Sources of cholesterol for steroidogenesis  
In the public but also in the medical community cholesterol is primarily 
perceived as a cardio-vascular risk factor. Although this is true cholesterol 
also plays an important role in many biological processes, for example as 
an essential structural component of mammalian cell membranes 
(Balodimos, Kealey, & Hurxthal, 1968; Cooper, 1978). Furthermore, it 
provides the basis for many steroid hormones such as estrogens, 
androgens, glucocorticoids or mineralocorticoids, which are produced in 
steroidogenic cells like adrenocortical cells or granulosa cells of ovaries 
(Brown, Kovanen, & Goldstein, 1979; Cooper, 1978; Elliott & Schally, 
1955). Its essentialness is illustrated by various diseases - such as 
congenital adrenal hyperplasia, Niemann Pick Disease and foam cell 
formation in arteriosclerosis - deriving from cholesterol transportation and 
storage dysfunctions (Newman, Murad, & Geer, 1971; Ribeiro et al., 
2001; Tee et al., 1995).  
In steroidogenic cells, intracellular cholesterol originates from several 
different sources (Morris and Chaikoff 1959). The first supply is granted 
by endogenous synthesis from acetate at the endoplasmic reticulum (ER) 
(Srere, Chaikoff, & Dauben, 1948). Endogenous cholesterol synthesis is 
regulated by various mechanisms, i.a. sterol-induced degradation of the 
rate limiting enzyme 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase 
(HMGCoA-reductase) (Horton, Goldstein, & Brown, 2002; Sever, Yang, 
Brown, Goldstein, & DeBose-Boyd, 2003).  
Second, Verschoor-Klootwyk, Verschoor et al. (1982) could show that 
normal adrenal steroidogenesis in rats depends upon cholesterol delivery 
from plasma and that adrenocorticotropic hormone (ACTH)-stimulated 
steroid production is increased remarkably in the presence of lipoproteins 
(Verschoor-Klootwyk, Verschoor, Azhar, & Reaven, 1982). Lipoprotein 
derived cholesteryl ester uptake can be distinguished into two pathways: 
receptor-mediated endocytosis and selective cellular uptake via scavenger  
-1- 
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receptor class B, type 1 (SR-BI) (Acton et al., 1996; Hoekstra et al., 
2009).  
For receptor-mediated endocytosis, apolipoprotein B- or E containing 
lipoproteins – mainly low density lipoproteins (LDL) - are processed via 
the LDL-receptor (Brown & Goldstein, 1986). After LDL has bound to the 
LDL-receptor, the ligand-receptor complex moves within the plasma 
membrane by diffusion to a region called “coated pits”, which contains 
predominantly the protein clathrin (Anderson, Brown, & Goldstein, 1977; 
Burridge, Feramisco, & Blose, 1980). These regions invaginate and form 
vesicles, which fuse with early endosomes, then with each other and 
finally with lysosomes (Goldstein, Brunschede, & Brown, 1975). While the 
LDL-receptor is recycled and moves back to the cell membrane, lysosomal 
acid lipase hydrolyses the delivered cholesteryl esters (Brown, Anderson 
et al. 1983). The unesterified cholesterol is transported through the 
lysosomal membrane by Niemann Pick C Protein type 1 and 2 (NPC1 and 
NPC2) for steroid synthesis or re-esterification by acyl CoA-cholesterol 
acyltransferase for storage in lipid droplets (LDs) (Goldstein, Dana, Faust, 
Beaudet, & Brown, 1975; Kwon et al., 2009; Xu, Benoff, Liou, Lobel, & 
Stock, 2007).  
Nevertheless, in rodents very large amounts of lipoprotein derived 
cholesteryl esters are processed by selective cholesteryl ester uptake via 
SR-BI (Glass, Pittman, Weinstein, & Steinberg, 1983). SR-BI seems to be 
essential for optimal adrenal function as impairment of this receptor 
induces adrenal insufficiency (Azhar, Leers-Sucheta, & Reaven, 2003; 
Hoekstra et al., 2009). Especially ACTH (or LH (luteinizing hormone)) 
stimulated steroid hormone production relies heavily on this cholesterol 
source (Azhar et al., 2003; Gwynne & Hess, 1980; Kraemer et al., 2007). 
For selective uptake, cholesterol-rich lipoproteins bind to SR-BI and 
release cholesteryl esters regardless of their lipoprotein composition 
without uptake of the lipoprotein itself (Glass et al., 1983; Reaven, Tsai, & 
Azhar, 1995). The cholesteryl esters are stored in LDs or hydrolyzed by 
hormone sensitive lipase (HSL) for transferral of cholesterol to 
mitochondria (Kraemer et al., 2004).  
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The third source of cholesterol, which can be transported to mitochondria 
for steroid synthesis, is provided by mobilisation of cholesteryl esters 
stored in lipid droplets. HSL hydrolyzes these cholesteryl esters to 
cholesterol. Experiments with HSL knockout adrenal cells (from mice) 
suggest that cholesterol coming from these stores accounts for 
approximately half of the basal steroid production (Kraemer. 2007). 
 
All three sources supply cholesterol for biosynthesis of steroid hormones, 
of which the first step is conversion of cholesterol to pregnenonlone by the 
rate limiting enzyme cholesterol side chain cleavage enzyme (P450scc), 
which is found in the inner mitochondrial membrane (Black, Harikrishna, 
Szklarz, & Miller, 1994). Pregnenonlone can be converted to progesterone 
by 3-hydroxysteroid dehydrogenase (3HSD) at the inner mitochondria 
membrane in association with the translocase of the inner mitochondria 
membrane 50 (Tim50) (Pawlak, Prasad, Thomas, Whittal, & Bose, 2011). 
Otherwise, pregnenolone exits the mitochondrion and serves as substrate 
for the steroid 17 alpha-hydroxylase/17,20 lyase (P450c17) in the ER. All 
further steps take place at the ER until the final step of glucocorticoid and 
mineralocortocoid synthesis, which involves the two isoenzymes steroid 
11β-hydroxylase (P450c11β) and aldosterone synthase (P450c11AS) 
resulting in cortisol and aldosterone, respectively (Ishimura & Fujita, 
1997; Takayama et al., 1996; White, Curnow, & Pascoe, 1994).  
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Fig. 1 Sources of cholesterol for steroidogenesis 
Three main sources supply cholesterol for steroidogenesis:  
I. a) Endocytotic uptake of cholesteryl esters (CE) from low density lipoproteins 
(LDL), uptake via the LDL receptor (LDLR). CEs are hydrolysed in lysosomes 
by the lysosomal acid lipase (LAL) and exported by the two proteins 
Niemann Pick C type 1 and 2 (NPC1 and NPC2).  
b) Selective CE uptake from high density lipoproteins (HDL) and LDL via 
scavenger receptor B type 1 (SR-BI). CEs are hydrolysed by hormone 
sensitive lipase (HSL) or stored in lipid droplets (LDs).  
II. Endogenous synthesis of cholesterol (C) from acetyl CoA at the Endoplasmic 
Reticulum (ER), rate limiting enzyme is Hydroxy-3-Methylglutaryl Coenzyme 
A Reductase (HMG-CoA-Red).  
III. CEs stored in LDs are hydrolysed by HSL. Free cholesterol can be stored in 
LDs as CE after re-esterification by acyl CoA-cholesterol acyltransferase 
(ACAT).  
Free cholesterol is imported into mitochondria via the transduceosome (see Figure 2). 
Steroidogenesis begins in mitochondria with conversion of C to Pregnenonlone (Preg.) by 
the cholesterol side chain cleavage enzyme (P450scc). Preg. is either exported to the ER 
or transformed into progesterone (Prog.) by the 3-hydroxysteroid dehydrogenase 
(3HSD). At the ER, the steroid 17 alpha-hydroxylase/17,20 lyase (P450c17) works on the 
substrates. After re-import into mitochondria, final transformations by the isoenzymes 
steroid 11β-hydroxylase and aldosterone synthase (P450c11β and P450c11AS) result in 
cortisol and aldosterone respectively.  
 
Figure 1 was designed according to sources quoted on page 1 to 3 
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1.2 Transport of cholesterol to mitochondria –  
       assumptions, hypotheses and speculations 
It is currently unclear how cholesterol is transported from its various 
sources – endogenous synthesis at the ER, lipoprotein derived free 
cholesterol and cholesteryl esters stored in LDs - to the inner 
mitochondrial membrane for conversion to pregnenolone.  
The best described part of this transportation process is the last step, in 
which cholesterol is transferred through the outer mitochondria membrane 
to the inner mitochondrial membrane by a protein complex named 
transduceosome (J. Liu, Rone, & Papadopoulos, 2006). Confocal 
microscopy and immunoblot studies could reveal the components: Acyl-
CoA binding domain containing 3 (ACBD3), the RIα subunit of cAMP 
dependent Protein Kinase A (PKARIα), voltage dependent anion channel 1 
(VDAC1), translocator protein 18kilodalton (kDa) (TSPO) in the outer 
mitochondrial membrane as well as the hormone-induced steroidogenesis 
acute regulatory protein (StAR) (J. Liu et al., 2006). Within this complex, 
TSPO is thought to constitute the channel for cholesterol import with its 
five α-helices serving as transmembrane segments through the outer 
mitochondrial membrane and the cholesterol-recognition amino acid 
consensus at the cytosolic carboxy-terminus (Korkhov, Sachse, Short, & 
Tate, 2010; H. Li, Yao, Degenhardt, Teper, & Papadopoulos, 2001). 
VDAC1 serves as anchor protein in the outer mitochondrial membrane and 
helps importing StAR (M. Bose, Whittal, Miller, & Bose, 2008). StAR binds 
and releases cholesterol dependent on phospholipid-induced 
conformational changes (Baker, Yaworsky, & Miller, 2005; H. S. Bose, 
Whittal, Baldwin, & Miller, 1999). Furthermore, its activation requires its 
localisation at the outer mitochondrial membrane so that it acts as the 
initiator of the transduceosome supplying cholesterol for ACTH induced 
steroidogenesis (H. S. Bose, Lingappa, & Miller, 2002). ACBD3 is a Golgi 
associated protein. Upon hormone stimulation it dissociates from the Golgi 
and brings protein kinase A (PKA) along to the outer mitochondrial 
membrane by binding to TSPO (H. Li, Degenhardt, et al., 2001). It is 
thought to function as an A-kinase anchoring protein (AKAP) bringing PKA 
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in close proximity with its substrates TSPO and StAR resulting in their 
phosphorylation (Papadopoulos, Liu, & Culty, 2007). Moreover, StAR 
activity was shown to be enhanced by phosphorylation (Dyson et al., 
2008). In 2012, Rone et al. identified an 800kDa protein complex, which 
includes polymerised TSPO and VDAC1 as well as the ATPase family AAA 
domain-containing protein 3 (ATAD3) and P450scc (Rone et al., 2012). 
ATAD3 is a well conserved ATPase (S. Li & Rousseau, 2011). It is 
anchored in the inner mitochondrial membrane, enriched at mitochondrial 
contact sites and its knock-out was found to result in decreased 
cholesterol flow between the ER and mitochondria (Da Cruz et al., 2003; 
Gilquin et al., 2010; S. Li & Rousseau, 2012). Hence, Rone et al. propose 
this complex acting as a metabolon transferring cholesterol directly to 
P450scc where it is transformed into pregnenolone (Rone et al., 2012).  
 
 
 
Figure 2 Import of cholesterol into mitochondria 
The transduceosome: voltage dependent anion channel (VDAC1) and translocator 
protein, 18kDa (TSPO), recruit Acyl-CoA binding domain containing 3 (ACBD3), which 
binds the RIα subunit of cAMP dependent Protein Kinase A (PKA-RIα), and steroidogenic 
acute regulatory protein (StAR) in response the hormone stimulation. TSPO is proposed 
to serve as channel, while VDAC1 anchors the complex to the OMM and StAR acts as 
initiator supplying cholesterol (C). ACBD3 functions as A-kinase anchoring protein so that 
PKA can phosphorylate StAR enhancing its activity.  
The metablonon: 800kD protein complex which contains the inner mitochondrial 
membrane proteins ATAD3 and P450scc in addition to TSPO and VDAC1. It is thought to 
bring cholesterol directly to P450scc for pregnenolone synthesis.  
 
OMM = outer mitochondrial membrane, IMS= intermembranous space, IMM = inner 
mitochondrial membrane  
 
Figure 2 was designed according to sources quoted on page 5 to 6 
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However, much less is known about the transportation of cholesterol from 
its various sources to the outer mitochondrial membrane before it is 
transferred to P450scc by the transcudeome/metabolon. As cholesterol is 
essentially insoluble in aqueous solution, it could be moved via protein-
bound transport, vesicular transport or transport within larger organelles, 
e.g. lipid droplets (Haberland & Reynolds, 1973).  
In steroidogenic cells, two members of the START domain super family – 
StAR-related lipid transfer (START) domain containing 4 (StARD4) and 
StAR-related lipid transfer (START) domain containing 5 (StARD5) – can 
bind cholesterol similarly to StAR and are discussed to be responsible for 
protein-bound transport of cholesterol to mitochondria (Soccio, Adams, 
Maxwell, & Breslow, 2005; Soccio & Breslow, 2003). These proteins are 
highly conserved and are lacking an amino-terminal sequence so that they 
are thought to be cytosolic proteins (Alpy & Tomasetto, 2005). 
Furthermore, StARD4 co-localises with acyl CoA-cholesterol 
acyltransferase and increases its activity in the ER (Rodriguez-Agudo et 
al., 2011). However, knock-out of StARD4 in mice appears to be 
compensated and only results in minor changes of weight and serum lipids 
(Riegelhaupt, Waase, Garbarino, Cruz, & Breslow, 2010).  
The second assumption – that vesicles transport cholesterol to the outer 
mitochondrial membrane – is based on numerous microscopic 
observations showing ER vesicles in close proximity to mitochondria (Frey 
& Mannella, 2000). Furthermore, a high concentration of cholesterol within 
cell membranes leads to increased rigidity of the membrane and hence 
promotes formation of vesicles through hydrophobic mismatch (Garcia-
Saez, Chiantia, & Schwille, 2007; Simons & Vaz, 2004). Thus, vesicles 
seem to play an important role in lipid homeostasis.  
The third possible mode of cholesterol transport involves lipid droplets, 
which are also often found in close proximity to mitochondria and 
discovered to be in physical contact with mitochondria (Novikoff, Novikoff, 
Rosen, & Rubin, 1980; Pu et al., 2011). Once thought of as an inert fat 
deport, lipid droplets are now recognised to be dynamic organelles with 
the ability to move along the cytoskeleton, e.g. to mitochondria (Shen et 
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al., 2012; Weibel et al., 2012). LDs consist of a neutral lipid core – mainly 
cholesteryl ester or triacylglycerine depending on cell type - surrounded 
by a monolayer of phospholipids and a wide array of associated proteins. 
While the proteome of cholesteryl ester containing LDs it not well studied, 
it was found out that on triacylglycerine lipid droplets these proteins 
include structural proteins, enzymes involved in metabolism, vesicular 
transport machinery and several cytoskeletal proteins (Cermelli, Guo, 
Gross, & Welte, 2006) laying the basis for an active role in lipid 
metabolism with storage, metabolic and transport properties.  
 
 
 
1.3 Lipid droplets (LDs) as potential deliverer of  
      cholesterol to mitochondria  
1.3.1 LDs as dynamic organelles in lipid metabolism 
The major break-through in accessing the role of LDs as dynamic 
organelles was reached by proteomic analyses of purified LD fractions 
revealing at least parts of the protein machinery on their surface.  
Some of the best investigated LD proteins are the perilipin family proteins 
(Plins), which not only have a structural function stabilising LDs but also 
control lipolysis by regulating access of HSL and adipose triglyceride lipase 
(ATGL) to LDs (Egan, Greenberg, Chang, & Londos, 1990; Greenberg et 
al., 1991). Only recently it was found out that the abundance of different 
Plin members differs between triacylglycerine and cholesteryl ester 
containing LDs. In steroidogenic cells, cholesteryl ester lipid droplets 
mainly contain Plin1c and Plin5 (Hsieh et al., 2012). The biological 
significance as it relates to steroidogenesis remains yet unknown 
(Kraemer, Khor, Shen, & Azhar, 2013).  
Mass spectrometry experiments have revealed more proteins – many of 
them enzymes - on LD surfaces that manifest the active role of LDs in 
lipid metabolism, such as HSL itself, lanosterol synthase, nicotinamide 
adenine dinucleotide (phosphate) (NAD(P))-dependent steroid 
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dehydrogenase-like protein, acyl-CoA synthetase and long chain family 
member (ACSL) 1,(Brasaemle, Dolios, Shapiro, & Wang, 2004).  
Furthermore, cytoskeleton proteins could be identified on LDs indicating 
their role as a dynamic organelle in lipid metabolism and explaining their 
broad distribution across the cell (Brasaemle et al., 2004; Krahmer et al., 
2013; Targett-Adams et al., 2003). For triacylglycerine lipid droplets, 
intact microtubules were found out to be required for triacylglycerine 
independent growth by complex formation and kinesin-1 to mediate plus-
end droplet motion (Bostrom et al., 2005; Shubeita et al., 2008). In 
adrenals, the intermediate filament vimentin, which is part of the 
cytoskeleton, was found to form a capsule around cholesteryl ester lipid 
droplets (Fuchs & Weber, 1994; Hall & Almahbobi, 1992, 1997). Vimentin 
not only interacts with proteins that show motor-like properties but also 
proteins with sterol binding properties as well as HSL (Chou et al., 2007; 
Shen et al., 2012; Wang, JeBailey, & Ridgway, 2002). Shen et al. 
discovered that the interaction with HSL affects lipolysis in addition to 
translocation of HSL to LDs (Shen, Patel, Eriksson, & Kraemer, 2010). In 
vimentin null mice, serum corticosterone concentrations, progesterone 
peaks in the oestrus cycle (in female mice) and stimulated serum 
progesterone concentrations were reduced suggesting a defect in adrenal 
and ovarian steroidogenesis (Shen et al., 2012).  
In summary, lipid droplets seem to be active organelles in lipid 
metabolism transporting their cargo along the cytoskeleton. However, the 
exact mechanisms mediating cholesteryl ester/cholesterol delivery from 
LDs to the transduceosome in the outer mitochondrial membrane for 
steroidogenesis are still unknown.  
 
1.3.2 Role of soluble N-ethylmaleimide-sensitive-factor 
attachment receptor (SNAREs) on LDs  
Interestingly, SNAREs were found to mediate fusion of triacylglycerine LDs 
(Bostrom et al., 2007). Originally, SNAREs were well known from 
membrane fusion of secretory pathways, e.g. synaptic exocytosis 
(Baumert, Maycox, Navone, De Camilli, & Jahn, 1989; Bennett, Calakos, & 
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Scheller, 1992; Trimble, Cowan, & Scheller, 1988). They can be 
differentiated into R- (arginine) and Q- (glutamine) SNAREs according to a 
key residue in the centre of their SNARE domain or into v- SNAREs 
(vesicular) and t-SNAREs (target-membrane) according to their position 
(Fasshauer, Sutton, Brunger, & Jahn, 1998). All SNAREs share a similar 
basic structure: At the carboxy-terminus, SNAREs are linked to a 
membrane, either by thioester linked acylgroups (e.g. synaptosomal-
associated protein 25 (SNAP25)) or by transmembrane domains (e.g. 
syntaxin) (Han, Wang, Bai, Chapman, & Jackson, 2004; Ungermann & 
Langosch, 2005). In-between the carboxy-terminus and the divergent 
amino-terminus the SNARE motif is found (Sutton, Fasshauer, Jahn, & 
Brunger, 1998). To initiate membrane fusion, the SNARE motifs of 
opposing SNAREs and a soluble N-ethylmaleimide sensitive factor adaptor 
proteins (SNAP) assemble into parallel, twisted, coiled-coil, four helix 
bundles (Antonin, Fasshauer, Becker, Jahn, & Schneider, 2002; Sutton et 
al., 1998). This exothermic reaction starts at the amino-terminus of the 
SNAREs and ends at the carboxy-terminus according to the zip-model and 
provides the energy for membrane fusion (Fasshauer, Otto, Eliason, Jahn, 
& Brunger, 1997; Sorensen et al., 2006). The disassembly of this complex 
is driven by concerted action of N-ethylmaleimide sensitive factor (NSF) 
and α-SNAP (alpha-soluble NSF-attachment protein) (Hayashi, Yamasaki, 
Nauenburg, Binz, & Niemann, 1995). The amino-terminus of NSF binds to 
the SNAP-SNARE complex while one of its two ATP (adenosine 
triphosophate) binding domain shows ATPase activity needed for 
disassembly (Nagiec, Bernstein, & Whiteheart, 1995; Tagaya, Wilson, 
Brunner, Arango, & Rothman, 1993).  
SNAREs interact with ras related in brain (rab) proteins, which are 
members of the Ras superfamily of GTPases, to mediate membrane fusion 
(Salminen & Novick, 1987; Schardt et al., 2009). Rab proteins cycle 
between an inactive guanosine diphosphate (GDP)-bound state and an 
active guanosine triphosphate (GTP)-bound state (Schlichting et al., 1990; 
Zerial & Stenmark, 1993). In the cytoplasm, GDP-Rab are bound by GDP-
dissociation inhibitors (GDI) and kept soluble (Alexandrov, Horiuchi, 
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Steele-Mortimer, Seabra, & Zerial, 1994; Ullrich et al., 1993). Removal of 
GDI by GDI-displacement factors and exchange of GDP for GTP by 
guanine nucleotide exchange factors leads to recruitment of Rabs to donor 
membranes and conversion into their active GTP-form (Andres et al., 
1993; Dirac-Svejstrup, Sumizawa, & Pfeffer, 1997; Ullrich et al., 1993). 
This allows Rab proteins to coordinate their switch regions so that 
effectors, such as tethering factors, can bind to the Rab protein (Barr & 
Lambright, 2010; Simonsen et al., 1998). For inactivation of Rabs at the 
acceptor membrane after vesicle fusion, a GTPase activating protein is 
required to assist with GTP hydrolysis so that GDP-Rab can be bound by 
GDI for re-cycling (Araki, Kikuchi, Hata, Isomura, & Takai, 1990). 
Rab proteins were found on LDs and shown to regulate interaction of LDs 
with early endosomes (Bartz et al., 2007; P. Liu et al., 2007). 
Furthermore, it was observed in an in-vitro assay that GTP affects 
interaction of LDs with mitochondria indicating that Rab proteins might 
mediate LD-mitochondria interaction (Pu et al., 2011).  
Beside Rab proteins SNAREs were found on LDs as well. In muscle and 
liver cells, LDs were found to be associated with NSF, α-SNAP and the 
SNAREs SNAP23 (synaptosomal-associated protein of 23 kDa), syntaxin-5, 
VAMP4 (vesicle-associated membrane protein 4) as well as SNAP25 
(Bostrom et al., 2007). Furthermore, in NIH 3T3 fibroblast, 
triacylglycerine LDs were found to form a complex with mitochondria, 
whose formation is decreased by siRNA (small interfering ribonucleic acid) 
knockdown of SNAP23 (Jagerstrom et al., 2009). SiRNA knockdown of 
SNAP 23 also leads to decreased beta-oxidation which indicates that the 
SNAP23 mediated complex is of functional relevance (Jagerstrom et al., 
2009). So SNARE components seem to play an important role for 
transport of triaclyglycerine to mitochondria. However, it is still unknown if 
SNARE components are also involved in transport of cholesterol via LDs to 
mitochondria for steroidogenesis.  
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2 Aim of this study and research strategy  
2.1 Aim of this study 
It is known that intracellular cholesterol is transported from its various 
sources to mitochondria for steroidogenesis. However, the exact 
transportation pathway and mechanisms involved are still unclear. LDs 
seem to play an important role in this process and may mediate the 
transport of cholesterol to mitochondria. The aim of this study is to 
determine if cholesterol is transported from lipid droplets to mitochondria 
in a SNARE-mediated manner. It will be investigated if the SNARE 
components SNAP23, SNAP25, NSF, syntaxin 17 and α-SNAP are involved 
in this process. Furthermore, the effect of cyotosolic components and GTP 
on cholesterol transport from LDs to mitochondria will be analysed.  
 
 
 
2.2 Research strategy/ approach  
Rat ovaries and adrenals will be used as a model. An in-vitro 
reconstitution bioassay will be used to model transportation of cholesterol 
via lipid droplets to mitochondria. Briefly, mitochondria of rat ovaries and 
adrenals, LDs and StAR will be added to various combinations of purified 
recombinant histidine (His)-tagged SNAREs. The medium will be analyzed 
for pregnenolone via a quantitative enzyme-linked immunosorbent assay 
(ELISA). The more cholesterol reaches mitochondria, the more 
pregnenolone will be produced. Cytosol and GTP will be added to 
investigate their effect on pregnenolone production and hence cholesterol 
transport from LDs to mitochondria.  
 
In particular, the effect of SNAP23, SNAP25, NSF and α-SNAP will be 
investigated as they have been found on triacyl glycerine lipid droplets 
(Bostrom et al., 2007). The effect of syntaxin 17 (Stx17) will be examined 
as it is abundantly expressed in steroidogenic cell types and specifically 
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localizes to smooth membranes of the ER, which are highly involved in 
lipid metabolism (Steegmaier, Oorschot, Klumperman, & Scheller, 2000). 
Purified recombinant StAR will be added to the in-vitro reconstitution 
assay as well to insure sufficient cholesterol transport across the 
mitochondrial membranes. Cytosol and GTP will be added as Rab proteins 
were found on LDs and GTP was observed to affect interaction of LDs with 
mitochondria in an in-vitro assay (Bartz, Zehmer et al. 2007; Liu, Bartz et 
al. 2007; Pu et al., 2011).  
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3 Material and Methods  
3.1 Cloning of recombinant SNARE proteins 
Cloning was used in order to produce vectors carrying a recombinant 
protein, which was then transferred into Escherichia coli (E. coli) 
(Bl21DE3) for induced expression. The purified proteins were later on used 
for reconstitution assays. 
 
3.1.1 Vector, deoxyribonucleic acid (DNA) sequence  
           of SNARE proteins, primer design and restriction  
           enzymes  
Vector: pET15b purchased by Novagen  
The polymerase chain reaction (PCR) amplification product was inserted 
into the vector behind the coding sequence of a 6xHis-tag in reading 
direction resulting in an amino-terminal His-tag. Hence, a fusion protein of 
the 6xHis-tag and the protein coded for by the amplified PCR was 
produced.  
DNA sequence, primers and restriction enzymes  
 Structure of the sense-primer 
Cytosine/Guanine rich base triplet for protection against nucleases – 
cutting sequence of the restriction enzyme – additional base to keep 
the insert within the reading frame if needed – Start codon and/or 
template sequence  
 Structure of the anti-sense-primer 
Cytosine/Guanine rich base triplet for protection against nucleases – 
cutting sequence of the restriction enzyme – complementary base 
pairs to the leading strand of the template beginning at the 3’end  
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Restriction enzymes and their cutting sequence are marked in green, start 
codons (or the first codon of the coding DNA sequence for truncated 
proteins) in yellow, stop codons in red (see below).  
The primers were produced by Elim Biopharm. 
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a= adenine, c = cytosine, g= guanine, t = tyrosine  
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3.1.2 DNA amplification by polymerase chain reaction  
         (PCR) 
The PCR for amplification of DNA was conducted as described previously 
by (Sambrook. J., 1989). Isolated DNA from mouse tissue was used as 
DNA template for the PCR if the PCR product was used for cloning. Whole 
cell extracts of E. coli were used as template for evaluation if the cloning 
was successful (check-PCR). Thereby, a single E. coli colony was 
resuspended in 15μl sterile water (H2O). After incubation at 30°C for 10 
minutes (min), 1μl of the cell suspensions was used as template DNA.  
 
Thermus aquaticus (Taq) DNA Polymerase (for check-PCRs) and Platinum 
Taq DNA Polymerase High Fidelity (TaqHIFI, Invitrogen) served as 
thermostable DNA polymerases whereupon TaqHifi ensured the sufficiency 
of the PCR product for cloning due to its proof reading ability.  
 Amount Volume 
DNA  20ng plasmid DNA or 
200ng genomic DNA 
as templates 
3µl 
10xbuffer  1% Triton X-100, 500 
mM KCl, 15mM 
MgCl2, 100mM 
Tris·HCl, pH 8.8 
5µl 
dNTPs 10mM each 4µl 
Primer_s 20pmol/μl each 1µl 
Primer_as 20pmol/μl each 1µl 
Taq or Taq HIFI  1µl 
H20 autoclaved, distilled 
(dist.) 
 35µl 
Total  50µl 
dNTP= deoxynucleoside triphosphate, Tris = tris-(hydroxymethyl)-
aminomethane, primer_s= sense-primer, primer_as= anti-sense-primer 
 - 19 - 
PCR-Program with 35 cycles  
 Temperature Duration 
Initial denaturation 94°C 2min 
Denaturation 94°C 30seconds (sec) 
Annealing 60 °C, ∆ 20°C 30sec 
Elongation 68°C 500 basepairs/min for 
Taq HIFI, 100 
basepairs/min for Taq 
Final elongation 68°C 2x elongation time 
Hold at 4°C Hold 
PCR machine: Mastercycler gradient – Eppendorf 
 
Afterwards, the PCR products were analysed by agarose gel 
electrophoresis. 
The PRC product was sequenced by ElimBio. 
 
3.1.3 Agarose gel electrophoresis  
Horizontal agarose gel electrophoresis was used to separate DNA 
fragments according to their molecular weight.  
1% weight per volume (w/v) agarose was dissolved in TAE buffer (40mM 
Tris-acetate, pH7.5, 20mM Na-acetate, 1mM EDTA) in a microwave. After 
cooling down to 60°C, ethidium-bromide (0.5μg/ml) for DNA visualization 
under UV light was added with a pipette and mixed with the pipette top 
before pouring the mixture into a cuboid mould with a comb for cooling 
down to room temperature (RT) and solidifying.  
The PCR product was mixed in 4:1 ratio with 5x loading dye (30% volume 
per volume (v/v) glycerol, 0.25% (w/v) bromphenol-blue, 0.25% (w/v) 
xylencyanol) and loaded into the pockets on the agarose gel. 
Commercially available molecular weight markers were used. The gels 
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were run in TAE buffer at 50V or 100V depending on the size of the gel. 
The negatively charged DNA, hence, moved to the anode and was 
separated according to its molecular mass. The separated DNA fragments 
were visualized under UV light (366 nm). 
 
3.1.4 Purification of PCR amplification products 
To purify PCR amplification products the “QIAquick Gel Extractoin Kit” was 
used.  
In brief, 3 volumes of buffer QG were added to 1 volume of gel (100mg 
~100µl). The mixture was incubated at 50°C for 10min and vortexed in-
between. After the gel had dissolved completely, 1 volume of isopropanol 
was added for DNA precipitation. After mixing, the sample was applied to 
a QIAquick spin column, which binds DNA, and centrifuged for 1min at 
179000g. The supernatant (sup) was decanted and the column was 
washed with 0.75ml of PE buffer (centrifugation at 17000g for 1min). The 
centrifugation was repeated after decanting the sup to remove the 
residual washing buffer. The QIAquick column was placed into a 1.5ml 
microcentrifuge tube. For elution, 40µl of EB buffer (10mM TrisCl, pH 8.5) 
were added. The column was rested at RT for 3min and then centrifuged 
for 1min at 17900g. The concentration of DNA was measured as described 
below. The DNA was stored at 4°C (PCR product) or at -20°C (plasmids).  
 
3.1.5 Measurement of DNA concentration  
In order to measure the DNA concentration the NanoDrop 1000 
Spectrophotometer by Thermo Scientific was used. 1µl sample was 
pipetted onto the end of a sampling arm containing a fibre optic cable. By 
closing the sampling arm a second fibre optic cable was then brought into 
contact with the sample causing the liquid to bridge between both fibre 
optic ends. A spectral measurement was made using a pulsed xenon flash 
lamp as light source. The instrument is controlled by PC software which 
saves the measured DNA concentration in a file. 
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3.1.6 Digestion of DNA with restriction endonucleases 
Restriction endonucleases were used for digestion of PCR products and 
vectors according to the following pipetting scheme. 
 
 For PCR products For vectors 
DNA  50μl (1 μg/μl) 20μl (1μg/μl) 
Enzyme specific buffer  5μl 5μl 
Enzyme  5U/1μg of DNA 5U/1μg of DANN 
H2O dist.  Filling the tube up to 
50μl 
Filling the tube up to 
50μl 
Total 50μl 50μl 
For 2h at 37°C  
The buffers were used according to the recommendations of NewEngland 
BioLabs Inc. After digestion, the DNA fragments were analysed by agarose 
gel electrophoresis and purified (as described above).  
If the plasmid was digested with only one restriction endonuclease, heat 
inactivated alkaline phosphatase (Invitrogen) was added to the digestion 
mixture for 20min at 37°C to prevent re-closing of the plasmid by 
removing 5’ phosphates prior to insert ligation.  
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3.1.7 Ligation of DNA fragments with ligation  
         enzymes  
 Amount 
Vector 100-200ng 
Insert 6x molar excess of the vector  
Buffer (10 fold) (50mM Tris·HCl, 10mM 
MgCl2, 1mM DTT, 1mM ATP, 5% (w/v) 
PEG-8000, pH 7.6) 
1.5μl 
T4-ligase (from bacteriophage T4)  0.5μl 
H2O dist.  To fill up to 15μl 
Total 15μl 
15h at 16°C  
The buffer and the T4-ligase were purchased from NewEngland BioLabs 
Inc.  
The ligation product was used for the transformation of competent E. coli.  
 
3.1.8 Heat shock transformation  
After ligation, the plasmid was transformed into DH5α E. coli for plasmid 
replication.  
For protein induction and expression the correct plasmid containing the 
insert was transformed into BL21-DE3 E. coli. For both E. coli stems the 
same transformation procedure was used.  
Competent E. coli cells were taken from the -80°C freezer and put on ice 
for 5min in an eppendorf tube (eppi). For testing and replicating plasmids, 
100µl of DH5α were transformed using the ligation mix. For protein 
expression 50µl of BL21-DE3 were used. The tubes were kept on ice and 
50ng of DNA was added for incubation on ice for 30min. Afterwards, the 
tubes with E. coli and DNA were heat-shocked for 45sec at 42°C to allow 
the plasmid to enter the bacteria and then put on ice for 2min to reduce 
damage to the E. coli cells. 1ml of lysogeny broth (LB) was added followed 
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by incubation for 1.5h at 37°C at 220rounds per minute (rpm). 100µl of 
the culture were spread on a LB-ampicillin (LB-amp) plate which was 
inoculated over night. Single colonies were picked after 12-16h.  
The constitution of the used media was as follows.  
For liquid cultures 
LB-medium: 0.5% (w/v) yeast extract, 1% (w/v) bacto-tryptone, 1% 
(w/v) NaCl. 
LB-Amp medium: LB-medium supplemented with ampicillin (100μg/ml) 
 
For solid media (plates) 
LB-medium supplemented with 2% (w/v) bacto-agar, autoclavation at 
120ºC for 20min.  
After the plates had cooled down to at least 50°C, ampicillin was added 
resulting in an ampicillin concentration of 100μg/ml.  
 
3.1.9 Miniprep for DNA Isolation from Escherichis coli (E.  
         coli) 
For isolation of plasmid DNA from E. coli the QIAprep Spin Miniprep Kit 
(250) was used.  
Briefly, a single E. coli colony was incubated in 5ml LB-amp medium over 
night at 37°C at 200rpm. The cells were harvested by centrifugation 
(6800g, 5min, RT) and then resuspended in 250µl of Buffer1. To lyse the 
cells 250µl of Cell Lysis Solution (Buffer2) were added and the tubes were 
inverted 8 times and then incubated for 3min at RT. After neutralisation 
with 350µl of Neutralisation Solution (Buffer3), the tubes were inverted 
several times again, followed by centrifugation (17900g, 10min, RT). The 
supernatant was transferred into QIAprep spin column by pipetting. The 
column was spun for 1min at 13000rpm for the lysate to pass trough the 
clearing membrane and the DNA to bind to the binding membrane. The 
column was washed with 750µl of PE Buffer by centrifuging the column for 
1min at 13000rpm. After decanting the buffer, the column was spun again 
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to dry the binding membrane. The QIAsprep spin column was placed into 
a clean eppi. 40μl of nuclease-free water or Elution Buffer were added to 
the DNA binding membrane to elute the DNA. The eppi was rested at RT 
for 2min and then centrifuged at 13000rpm for 1min. Afterwards, the 
filtrate was stored at -20°C.  
 
3.1.10 Control of orientation of the insert 
If an insert is digested with the same restriction endonuclease at both 
ends, orientation of the insert within the plasmid needs to be checked. 
Therefore, each plasmid containing the insert was digested with a 
restriction endonuclease that only cuts once in the insert and once in the 
vector (procedure see above). Depending on the orientation of the insert, 
the obtained fragment can have two different sizes. Preferably, an enzyme 
was used that cuts close to one end of the insert to obtain a great 
difference in size between the two possible fragments. The digestion 
mixture was analyzed on an agarose gel to determine the size of the 
fragment as described above.  
Insert Restriction 
enzymes 
Fragment sizes 
for right 
orientation (base 
pairs)  
SNAP23 SacI, ApaI 1138 and 5203 
SNAP25 HindIII 631 and 5698  
Stx17 BGlII 983 and 5630 
NSF XhoI 650 and 7292  
Alpha-SNAP SphI 434 and 6595 
STAR XhoI 571 and 5991 
 
3.1.11 Glycerol stocks  
5ml of LB-amp were inoculated with a single E. coli colony which had 
grown to log-phase. 800µl of this culture were given into a sterile tube 
containing 200µl of autoclaved 80% glycerol. The sample was mixed 
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briefly by vortexing and then stored at -80 C. To grow cells from the 
stock, the surface of the glycerol stock was carefully touched with a sterile 
pipette tip, which was then given into 3ml LB-amp media.  
 
 
 
3.2 Induction, expression and purification of 
recombinant SNARE proteins  
3.2.1 Induction of recombinant protein expression in  
         E. coli and harvesting the cells (Bl21DE3) 
SNAP25, SNAP23, α-SNAP, Stx17 
A 3ml LB-amp culture derived from glycerol stocks of the recombinant 
SNARE proteins was grown over night (37°C, 220rpm). In the morning, 
1ml of this culture was diluted with 100ml of LB-amp and cultured at 
37°C, 220rmp until an optical density at 600nm (OD600) of 0.6 – 0.75 
was reached. 1ml of the culture was centrifuged for 3min at 4000g and 
the pellet was resuspended in Laemmli buffer (200µl /OD; 60mM Tris·HCl, 
pH 6.8, 2% (w/v) sodium dodecyl sulfate (SDS), 10% glycerol, 5% (v/v) 
β-mercaptoethanol, 0.05% (w/v) bromphenol-blue) and heated for 5min 
at 95°C to serve as a negative control before induction. Then the protein 
expression was induced with 1ml 0.1M isopropyl-β-D-
thiogalactopyranoside (IPTG)/100ml culture for 2.5 - 3h at 37°C. IPTG 
binds to the lac-repressor leading to a conformational change and hence 
the disinhibition of the operator of the lac-operon. Thus, the inserted 
SNAP/Stx-sequences downstream of the lac promoter is transcribed and 
translated.  
1ml of the induced culture was taken as a positive control after 1h, 2h and 
3h and treated like the negative control (see above). The rest of the cells 
was spun down at 2500g for 5min at 4°C and stored at -20°C. 
 - 26 - 
The negative and positive controls were separated by sodium dodecyl 
sulfate -polyacrylamide gel electrophoresis (SDS-PAGE, see 3.2.3) 
according to their molecular weights. Then they were coloured with 
commassie blue (see 3.2.4) to check if induction was successful and which 
induction time shows the highest yield without degradation of the 
recombinant proteins.  
For STAR and NSF the same protocol was applied with some changes to 
ensure that STAR is not degraded and that NSF is in the soluble fraction 
despite its size of 82kDa.  
 
STAR 
For StAR, induction was started at OD600 of 0.6 (not higher) for 2.5h. 
Longer incubation can result in increased degradation of the STAR protein.  
 
NSF  
For NSF, a colony from the glycerol stock was grown in 3ml LB-amp for 
8h. Then the 3ml culture was diluted with 100ml LB-amp and grown until 
an OD600 of 0.6 was reached. The culture was induced with 1ml 0.1M 
IPTG/100ml culture over night at 25°C. Higher induction temperature 
results in the recombinant protein being locked up in inclusion bodies.  
 
3.2.2 Purification of recombinant proteins expressed  
         in E. coli (Bl21DE3) 
After the recombinant plasmid had been transferred into E. coli by heat 
shock transformation and the expression of the recombinant protein had 
been induced by IPTG, the cells were resuspended in 5ml of lysis buffer 
(10mM Tris pH7.5, 130mM NaCl, 1% Triton X100 (for NSF 2%), Protease 
Inhibitor 1:1000, Phosphatase Inhibitor 1:100). Incubation at 4°C in the 
overhead shaker for 60min followed. Every 10min the cells were disrupted 
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by sonication (level 4, 30%, in ice water, for 10sec). The lysed cells were 
centrifuged at 20,000g for 30min at 4°C.  
The soluble recombinant proteins were purified using nickel-nitrilo triacetic 
acid (Ni-NTA) Agarose beads. The beads were washed 4 times with 6xHis 
washing buffer (50mM sodium phosphate, 300mM NaCl, 10% glycerol, 
pH8). While washing the beads were kept at 4°C and centrifuged at 500g 
for 4min. For 750µl of beads 750µl of 6xHis washing buffer were used for 
each wash. Then the beads were resuspended in the same volume of lysis 
buffer. 150-200µl of beads (in lysis buffer) were added to 1ml of sup each 
and incubated over night at 4°C in the overhead shaker. The His-tag binds 
the to the nickel ion so that the recombinant protein is connected to the 
beads.  
The next morning the beads were washed 2 times with 6xHis washing 
buffer (incubation on the overhead shaker for 5min at 4°C and 
centrifugation at 500g for 4min at 4°C) and 2 times with 6xHis washing 
buffer containing 20mM imidazole.  
Then the proteins were eluted from the beads by incubating consecutively 
with 0.5ml of 6xHis washing buffer containing 100mM 200mM /300mM 
/500mM imidazole for 5min each (for NSF 200mM imidazole incubation for 
7min) at RT on a rocking platform. The beads were centrifuged down at 
500g for 4min and the elution fractions (1 to 4) were collected in eppis, 
alliquoted and stored at -20°C. The elution fractions were tested for their 
content of recombinant protein and purity by SDS-PAGE and commassie 
blue staining (see below). 
 
3.2.3 Sodium dodecyl sulfate -Polyacrylamide gel  
         electrophoresis (SDS-PAGE) 
SDS-PAGE separates the proteins under denaturing conditions according 
to their molecular weights in a one-dimensional way. Concentration of 
acrylamide and bisacrylamide varied according to the moleculare sizes of 
the loaded proteins. However, mainly 14% gels were used, which were 
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self-poured (for exact compositions of the gels see table below). The 
volume of the loaded protein varied between 5 and 15μl which equals 
amounts of 5-30μg.  
The commercially available proteins mixture SeeBlue® Pre-Stained 
Standard (Invitrogen) with 4 - 250kDa served as marker. For 
electrophoresis, 35mA for 60min was used for gels of approximately 14cm 
x 9cm x 0.1cm. Otherwise 125V were applied for precast gels 9cm x 10cm 
(PAGEr™ Gold Gels, 9 cm x 10 cm, 4-12%, Lonza) according to the 
protocol recommendations by Lonza.  
 Separating Gel  Stacking 
gel 
%Acrylamide 20 10 12.5 14 15 16 17.5 5 
30%  (w/v) 
Acrylamide  
0.33% (w/v) 
Bisacrylamide 
(ml)  
6.7 5.7 6.5 7.9 8.5 9.0 9.7 0.83 
1M Tris/HCl, 
pH 8.8 (ml) 
3.7 6.5 6.5 6.5 6.5 6.5 6.5  
0.6M 
Tris/HCl, pH 
6.8(ml)  
       0.5 
H2O (ml) 1.6 4.5 3.4 3.0 1.74 1.2 0.5 3.6 
10% (w/v) 
SDS (µl) 
100 167 167 167 167 167 167 50 
TEMED (µl) 25 10 10 6 6 6 6 5 
10%(w/v) 
APS (µl) 
50 100 100 84 84 84 84 25 
Total (ml) 10 17 17 17 17 17 17 5 
TEMED = N,N,N',N'-Tetramethylethylendiamin, APS = Ammonium 
persulfate 
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Electrophoresis buffer: 50mM Tris base, 384mM glycine, 0.1% (w/v) SDS, 
pH 8.3 without adjustment. 
 
3.2.4 Staining of SDS -polyacrylamide-gels with  
         coomassie blue  
For staining SDS-Polyacrylamid-gels with coomassie blue (1g/l coomassie 
R250, 10% glacial acetic acid, 40% methanol, 50% distilled H2O), the gel 
was rinsed with distilled water three times. Then, it was put into a plastic 
box and fully covered with coomassie blue for 30min. Afterwards, the gel 
was fully covered with destainer (20% methanol, 10% glacial acetic acid, 
70% distilled H2O). The gel was heated in the microwave for 15sec and 
then destained over night with a small paper towel positioned next to the 
gel to absorb the stain.  
 
3.2.5 Determination of protein concentration via BCA  
         Pierce Protein Assay Kit  
For detection and quantification of total protein the Thermo Scientific 
Pierce BCA Protein Assay was used. In this procedure, Cu2+ is reduced to 
Cu1+ by proteins in an alkaline environment. Chelatation of BCA with 
protein-bound Cu1+ leads to a purple colour change. This BCA-Cu-
complex exhibits a strong linear absorbance with increasing protein 
concentrations.  
The BSA Standard Curve covered concentrations from 0µg/ml to 
2000µg/ml of bovine serum albumin (BSA). The working reagent was 
prepared according to the kit’s protocol with 50 parts of BCA Reagent A 
and 1 part of BCA Reagent B. The microplate procedure was performed 
with 25µl of each standard and 5µl and 2µl of each sample. 200µl of the 
Working Reagent were added. The plate was mixed on a plate shaker for 
30sec. Then the plate was covered and incubated at 37°C for 30min. After 
cooling the plate to RT, the absorbance was measured at 562nm on a 
plate reader.  
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3.3 Animal model  
Wild-type Spragule Dawley rats with a weight of at least 180g, aged 
between 3 months and 24 months were used. Rats were maintained in the 
animal facility at the Veterans Affairs (VA) Palo Alto Health Care System 
on a 12-h light-dark cycle. All procedures were in accordance with 
institution guidelines and approved by the institutional animal care and 
use committee of VA Palo Alto Health Care System. Animal 
experimentation was conducted in accordance with accepted standards of 
humane animal care. In brief, rats were killed by decapitation or CO2 
intoxication and the adrenal glands and/or ovaries were aseptically 
removed and put into ice-cold PBS (NaCl 137mM, KCl 2.7mM 
Na2HPO4*2H2O 10mM, KH2PO4 2.0 MM pH 7.4) and dissected free of fat 
for isolation of mitochondria.  
 
 
 
3.4 Isolation of mitochondria from rat adrenals  
      and ovaries  
After sacrificing the rats, adrenals and/or ovaries were removed and put 
into PBS. From this step onwards all actions were performed on ice. Fat 
was removed from the organs and the cleaned adrenals/ovaries were cut 
into very little pieces with scissors. The pieces were put into the glass 
tube of a dounce homogenizer. For 6 adrenals or ovaries 2ml of sucrose-
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer (10mM 
HEPES, 250mM sucrose, H2O, 10µl/ml protease inhibitor and 10µl/ml 
phosphatase inhibitor) were used. The mixture was homogenized on ice 
by douncing it about 15 times until all the lumps had vanished. The 
homogenized organs were decanted into an eppi and centrifuged at 700g, 
4°C for 10min to remove the bulky fragments. The supernatant was then 
centrifuged at 12000g for 15min at 4°C. The pellet contained 
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mitochondria and was resuspended in about 1ml of Sucrose-HEPES buffer 
and washed once while the sup (=cytosol) was stored at 4°C. Then the 
washed mitochondria were resuspended in a small volume of Sucrose-
HEPES buffer (about 400µl for 6 adrenals/ovaries) and kept on ice. The 
concentration of mitochondria was measured using the Pierce BCA Protein 
Assay Kit.  
 
 
3.5 Reconstitution assay and preparation of the  
      lipid emulsion (LE) 
The reconstitution assay was performed in glass tubes. For each reaction 
the total volume was 100µl. The amount of Sucrose-HEPES buffer was 
calculated in advance and given into the tube first. The other components 
were added in the same order as listed below. 
1) succinate with a final concentration of 5mM 
2) 2µl of lipid emlusion if needed 
3) 1µg of each recombinant protein needed 
4) GTP or guanosine 5'-O-[gamma-thio]triphosphate (GTPγS) with a 
total amount of 10µg/reaction if needed 
5) Cytosol with a total amount of 100µg of protein/reaction if needed 
6) 200µg of purified mitochondria  
After mixing the reagents by gently shaking the tube, the assay was left 
at RT for 20min. Then the mitochondria were pelleted down by 
centrifugation at 1500g for 15min at 4°C. The supernatant was 
transferred into a fresh glass tube using a pipette and stored at -20C.  
The lipid emulsion was prepared one day before it was used for 
reconstitution assays. 2.7mg cholesterol (Invitrogen) and 307µl 
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phosphatidylcholine were given into a glass tube. The mixture was dried 
under a constant flow of gaseous nitrogen to evaporate the chloroform in 
which phosphatidylcholine was suspended. Afterwards, the dried lipids 
were resuspended in 500µl KPO4-taurocholic acid buffer (0.02mM KPO4, 
0.01mM taurocholic acid, H2O) and sonicated on ice 4 times, 10 beats 
each time with a 30sec break in-between. Within this buffer, taurocholic 
acid served as emulsifier. The lipid droplet containing emulsion was stored 
at 4°C over night.  
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3.6 Quantitative pregnenolone ELISA 
The ALPCO IMMUNOASSAY Pregnenolone ELISA Kit was used.  
In this enzyme-linked immunosorbent assay, rabbit anti-pregnenolone 
antibodies are bound to the 96-well plate. The pregnenolone-containing 
sample (or standard or control) is given into the well together with a 
buffer containing a pregnenolone-biotin conjugate so that pregnenolone 
and conjugate compete for the binding position at the well-bound 
antibody.  After washing, a streptavidin horseradish peroxidase (HRP) 
conjugate is added, which binds to the biotin-conjugate. 
Tetramethylbenzidine serves as substrate for the HRP and is oxidized with 
hydrogen peroxide serving as oxidising agent leading to a colour change. 
Sulfuric acid is used as stop solution. Hence, colour intensity is indirectly 
proportional to the pregnenolone concentration in the sample (or standard 
or control).  
The Assay procedure instructions were followed carefully 
(http://www.alpco.com/pdfs/11/11-PREHU-E01.pdf). Briefly, after 
preparing all the working solutions, 50µl of each standard, control and 
sample were given into a well. The controls and the standards were 
performed in duplicate. 100µl of biotin conjugate working solution were 
added and the plate was incubated on a shaker (200rpm) for 1h at RT. 
After washing the wells 5 times with 300µl of diluted wash buffer, the 
plate was tapped firmly against absorbent paper until all the wells were 
dry. 150µl of HRP conjugate working solution were pipetted into each well 
with a multichannel pipette. The plate was incubated on a shaker 
(200rpm) for 30min at RT. After the same washing procedure as before, 
150µl of TMB substrate were given into each well at timed intervals 
(10sec). The plate was incubated on a shaker (200rpm) at RT for 14min. 
Then 50µl of stop solution were pipetted into each well at the same timed 
intervals as before (10sec). The plate was read on a microwell plate 
reader at 450nm within 5min after addition of stop solution. The standard 
curve is a semi-log curve. 
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3.7 Statistics applied  
The reconstitution assay was performed with at least three replicates per 
treatment. All results within the measuring range of the pregnenolone 
ELISA (0-25ng/ml, sensitivity 0.054 ng/ml) were taken into account. For 
calculating mean, standard deviation (SD) and confidence intervals (CI) as 
well as for displaying the results as graphs, the program GraphPad Prism 
6 was used. Furthermore, GraphPad Prism 6 was utilized to test for 
statistical significance between different treatments (tests see below) and 
to visualize the distribution of variances in a graph. Logarithms of 
pregnenolone concentration and variances were calculated with Microsoft 
Excel.  
All sets of data showing homoscedasticity were analysed by one-way 
analysis of variances (ANOVA). To avoid type I errors, for multiple 
comparisons the unpaired parametric Tukey’s multiple comparison test or 
Sidak’s multiple comparison test were utilized. For data sets displaying 
heteroscedasticity Dunn’s multiple comparison test was applied. p-values 
of <0.05 were considered significant and confidence intervals are shown in 
square brackets.  
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4 Results  
4.1 Induction, purification and storage of SNAREs  
      and StAR 
In order to assess the effect of SNAREs on cholesterol transport via lipid 
droplets to mitochondria in an in-vitro reconstitution assay, recombinant 
SNAREs and StAR needed to be cloned. The recombinant proteins had to 
fulfil certain requirements to be functional in the reconstitution assay: 1) 
They need to be inducible. 2) After purification they have to be in a solute 
state to be functional for the in-vitro assay. 3) The proteins must stay 
intact and must not be degraded during expression or purification. Before 
the recombinant SNAREs were used for reconstitution assays, fulfilment of 
these requirements was tested.  
 
4.1.1 Induction of SNAREs  
All recombinant proteins have been expressed in E. coli. To test 
inducibility and rate of induction of recombinant SNAREs and StAR, the 
proteins expressed by each E. coli culture have been separated by SDS-
PAGE and visualized by coomassie-blue staining 0, 1, 2 and 3 hours after 
induction (0, 1, 10, 25 hours after induction for NSF). All recombinant 
proteins show a prominent band increasing with time of induction at the 
height predicted by their molecular mass. For NSF the band appears after 
10 hours of induction and is smaller than the bands of the other 
recombinant proteins.  
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Figure 3 Induction of recombinant SNAREs and StAR  
A Coomassie-blue stained sodium dodecyl sulfate -polyacrylamide gel, induction of 
SNAP23 (23kDA) after 0, 1, 2 and 3 hours ;B Coomassie-blue stained sodium dodecyl 
sulfate -polyacrylamide gel, induction of Stx17 (17kDa) after 0, 1, 2 and 3 hours; C 
Coomassie-blue stained sodium dodecyl sulfate -polyacrylamide gel, induction of SNAP25 
(25kDa) after 0, 1, 2 and 3 hours; D Coomassie-blue stained sodium dodecyl sulfate -
polyacrylamide gel, induction of StAR (37kDa) after 0, 1 and 3 hours; E Coomassie-blue 
stained sodium dodecyl sulfate -polyacrylamide gel, induction of α-SNAP (35kDa) after 0, 
1, 2 and 3 hours; F Coomassie-blue stained sodium dodecyl sulfate -polyacrylamide gel, 
induction of NSF (82 kDa) after 0, 1, 10 and 25 hours 
 
 
 SNAP23 Stx17 
SNAP25 
StAR 
αSNAP 
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4.1.2 Purification and storage of SNAREs and StAR  
After induction, the recombinant proteins were purified and collected in 
elution fractions containing different concentrations of imidazole. The 
proteins of the elution fractions were separated by SDS-PAGE and 
visualized by coomassie-blue staining. For each recombinant protein, 
elution fraction 2 shows a bigger band than elution fraction 1 at the height 
of the molecular weight of the protein.  
    1    2      M
SNAP23A
elution fraction 
alpha-SNAP
  1          2         1      2  
Stx17
100
70
50
35
24
 
 
SNAP 25
       1           2      1           2           M 
StAR
       1         2     M 
B
elution fraction 
NSF
 
Figure 4 Elution fractions of purified SNAREs and StAR  
A Elution fraction 1 (100mM imidazole) and 2 (200mM imidazole) of Stx17 (17kDa), 
alpha-SNAP (35kDa) and SNAP23 (23kDa); B Elution fraction 1 (100mM imidazole) and 2 
(200mM imidazole) of NSF (82kDa) and SNAP25 (25kDa) and StAR (37kDa)  
StAR 
SNAP25 
NSF 
Stx17, 
SNAP23 
αSNAP 
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4.2 Results of the in-vitro reconstitution assay  
An in-vitro reconstitution assay was used to model cholesterol transport to 
mitochondria via LDs and to investigate the effect of SNAREs on this 
process. In the mitochondrial matrix, cholesterol was converted to 
pregnenonlone, of which the concentration was measured by ELISA. 
Results were summoned in 8 groups for comparison of pregnenolone 
concentrations within these sets. The basic constituents of the 
reconstitution assay - amount of mitochondria, sucrose-HEPES-buffer and 
succinate– were kept constant. Mitochondria were isolated from rat 
adrenals and ovaries to test the effect of SNAREs in both organs (group 1 
and 2 respectively). Furthermore, the combination of the added 
recombinant SNAREs was altered to find out which arrangement has the 
biggest effect on the pregnenolone concentration (group 6). It was also 
investigated if GTP, GTPγS and cytosol from rat adrenal cells (groups 3-5) 
have an effect on pregnenolone concentrations. BSA and imidazole served 
as negative controls (groups 7 and 8 respectively).  
 
Group Mitochondria  Treatments 
1 ovarian None 
  LE 
  LE+StAR 
  LE+StAR+SNAREs 
2 adrenal None 
  LE 
  LE+StAR 
  LE+StAR+SNAREs 
3 adrenal LE 
  LE+cytosol 
  LE+StAR 
  LE+StAR+cytosol 
  LE+StAR+SNAREs 
  LE+StAR+SNAREs+cytosol 
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4  adrenal LE+StAR+cytosol 
  LE+StAR+cytosol+GTP 
  LE+StAR+cytosol+GTPγS 
5 adrenal LE+StAR+SNAREs+cytosol 
  LE+StAR+SNAREs+cytosol+GTP 
  LE+StAR+SNAREs+cytosol+GTPγS 
6 adrenal None 
  LE 
  LE+StAR 
  LE+StAR+SNAREs 
  LE+StAR+SNAP23 
  LE+StAR+SNAP25 
  LE+StAR+Stx17 
  LE+StAR+NSF+α-SNAP+SNAP25 
  LE+StAR+ NSF+α-SNAP+SNAP23 
  LE+StAR+ NSF+α-SNAP 
  LE+StAR+SNAP25+SNAP23 
  LE+StAR+ NSF+α-SNAP+SNAP23+SNAP25 
7 adrenal LE 
  LE+StAR 
  LE+StAR+SNAREs 
  LE+StAR+BSA 
8 adrenal LE+StAR 
  LE+StAR+SNAREs 
  LE+StAR+60mM imidazole 
LE=lipid emulsion, StAR=recombinant StAR, SNAREs= SNAP25, SNAP23, 
NSF, α-SNAP, Stx17, BSA=bovine serum albumin 
 
4.2.1 Test for homoscedasticity  
In order to pick a correct statistical test for evaluating significance 
between pregnenonlone concentrations of different treatments, the results 
were scanned for homoscedasticity or heteroscedasticity, respectively. 
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Data were summoned in groups as described above. The distribution of 
variances for different treatments is displayed below. For group 1, 6, 7 
and 8 variances of the pregnenolone concentrations (ng/ml) are shown. 
Heterogeneous conditions e.g. concerning age (3 to 24 months old rats) 
and killing methods (decapitation vs. CO2 intoxication) or degree of 
purification of recombinant proteins lead to an increased range of 
variances. Hence, for the affected groups (2, 3, 4 and 5) variances of the 
natural logarithm (ln) of pregnenolone concentrations are demonstrated in 
order to preserve homoscedasticity. Therefore, the natural logarithm of 
the respective pregnenolone concentrations was also used for further 
statistical testing. Except from group 4, all groups show a homoscedastic 
distribution of variances.  
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Figure 5 Distribution of variances 
A Variances of groups 2, 3, 4 and 5, variance of ln(pregnenolone concentration); B 
variances of groups 1, 6, 7 and 9, variance of pregnenolone concentration ((ng/ml)^2) 
 
4.2.2 Reconstitution assay with mitochondria isolated  
         from rat ovaries (group 1) 
Mitochondria were isolated from rat ovaries (see 3.4). The pregnenolone 
concentration of the reconstitution assay was measured by ELISA under 
four conditions:  
1) mitochondria (M) only,  
2) addition of LE,  
3) addition of LE and recombinant StAR,  
4) addition of LE, recombinant StAR and all cloned recombinant SNAREs 
(SNAP23, SNAP25, Stx17, NSF and α-SNAP)).  
The pregnenolone concentration of the fourth condition 
(M+LE+StAR+SNAREs) was significantly higher in comparison to the three 
other treatments (p<0.01). The mean differences were:  
groups 1, 6, 7 and 8 
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 M vs. M+LE+StAR+SNAREs -0.2370 [CI-0.3596 to -0.1144 ], p<0.01 
 M+LE vs. M+LE+StAR+SNAREs -0.2037 [CI -0.3262 to -0.08108] , 
p<0.01 
 M+LE+StAR vs. M+LE+StAR+SNAREs -0.2043 [CI -0.3269 to -
0.08175], p<0.01 
 
 
 
**
**
**
 
A 
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Figure 6 A Pregnenolone concentration (ng/ml) of the reconstitution assay of group 1, 
mitochondria (M) were treated with LE, LE+StAR  and LE+StAR+SNAREs, values are 
shown as mean +/- SD for three independent experiments, p<0.01 (**) Tukey’s multiple 
comparison test B Mean difference between two treatments of group 1 with 95% CI, 
Tukey's multiple comparisons test 
 
4.2.3 Reconstitution assay with mitochondria isolated  
         from rat adrenals (group 2)  
Mitochondria were isolated from rat adrenals (see 3.4). The pregnenolone 
concentration of the reconstitution assay was measured by ELISA under 
the same conditions as before (4.2.2):  
1) mitochondria only,  
2) addition of LE,  
3) addition of LE and recombinant StAR,  
4) addition of LE, recombinant StAR and SNAREs (SNAP23, SNAP25,  
    Stx17, NSF and α-SNAP).  
A significant difference was found between ln (pregnenolone 
concentrations) of  
 M vs. M+LE (mean difference -3.397 [CI -4.684 to -2.110] p<0.0001)  
 M vs. M+LE+StAR (mean difference -4.145 [CI -5.395 to -2.894] 
p<0.0001),  
B 
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 M vs. M+LE+StAR+SNAREs ( mean difference -5.731 [CI -6.951 to -
4.512] p<0.0001),  
 M+LE vs. M+LE+StAR+SNAREs (mean difference -2.335 [CI 3.256 to 
-1.413] p<0.0001)  
 M+LE+StAR vs. M+LE+StAR+SNAREs (mean difference -1.587 [CI -
2.457 to -0.7168] p<0.0001) 
 
. 
****
****
****
****
****
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Figure 7 A Natural logarithm (ln) of pregnenolone concentrations (ng/ml) of 
reconstitution assays of group 2, M were treated with LE, LE+StAR and 
LE+StAR+SNAREs, values are shown as mean +/- SD for twenty-four independent 
experiments, p<0.0001 (****), Tukey’s multiple comparison test B Mean difference 
between two treatments of group 2with 95% CI, Tukey's multiple comparisons test 
 
In summary, pregnenolone concentrations in both assays – with adrenal 
and ovarian mitochondria – show the same pattern of significantly higher 
values when SNAREs are added (46fold increase for adrenals). Moreover, 
with adrenal mitochondria a significant increase of the pregnenolone 
concentration was found under addition of LE and LE+StAR to 
mitochondria and significance levels are higher for adrenals than for 
ovaries (p<0.0001 and p<0.01 respectively). Furthermore, rat adrenals 
are bigger than rat ovaries and easier to homogenize for mitochondria 
isolation, which results in a higher yield of mitochondria and need for less 
animals. Therefore, the following experiments will be performed with rat 
adrenals only.  
 
4.2.4 Effect of different combinations of SNAREs on  
         pregnenolone concentrations of reconstitution  
         assays (group 6)  
It was shown that all SNAREs together (SNAP23, SNAP25, Stx17, NSF and 
α-SNAP) lead to an increase in pregnenolone concentration in 
reconstitution assays. Different combinations of SNAREs were tested to 
B 
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find out which single SNARE or which combination accounts for the rise in 
pregnonlone concentration.  
 
A significant difference of pregnenolone concentrations was found 
between:  
 M+LE+StAR vs. M+LE+StAR+SNAP23 (p<0.01)  
 M+LE+StAR vs. M+LE+StAR+NSF+α-SNAP+SNAP25 (p<0.01)  
 M+LE+StAR vs. M+LE+StAR+NSF+α-SNAP+SNAP25+SNAP23 
(p<0.01)  
 M+LE+StAR vs. M+LE+StAR+SNAREs (p<0.0001)  
 M+LE+StAR+SNAREs vs. all other combinations (p<0.05, p<0.01, 
p<0.0001) except from 
 M+LE+StAR+SNAREs vs. M+LE+StAR+NSF+α-SNAP+SNAP25 
+SNAP23 (p>0.05)  
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Figure 8 A Pregnenolone concentrations (ng/ml) of reconstitution assays of group 6, M 
were treated with LE+StAR, LE+StAR+SNAP23, LE+StAR+SNAP25, LE+StAR+Stx17, 
LE+StAR+ NSF+αSNAP, LE+StAR+ SNAP23+SNAP25, LE+StAR+ NSF+αSNAP+SNAP23, 
LE+StAR+NSF+αSNAP+SNAP25, LE+StAR+NSF+αSNAP+SNAP23+SNAP25, values are 
shown as mean +/- SD for six independent experiments, p<0.05 (*), p<0.01 (**), 
Sidak’s multiple comparison test; B Pregnenolone concentration (ng/ml) of the 
reconstitution assay of group 6, M were treated with LE+StAR, LE+StAR+SNAREs, 
LE+StAR+SNAP23, LE+StAR+SNAP25, LE+StAR+Stx17, LE+StAR+ NSF+αSNAP, 
LE+StAR+SNAP23+SNAP25, LE+StAR+NSF+αSNAP+SNAP23, LE+StAR+NSF+αSNAP+ 
SNAP25, LE+StAR+NSF+αSNAP+SNAP23+SNAP25, values are shown as mean +/- SD 
for six independent experiments, p<0.05 (*), p<0.01 (**), p<0.0001 (****); Sidak’s 
multiple comparison test  
 
Confidence intervals for mean differences between two treatments are 
displayed below.  
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Comparison of treatments 
Mean 
difference 
95% CI, 
upper end 
95% CI, 
lower end 
M LE StAR - M LE StAR SNAREs -1,606611 -0,929997 -2,283225 
M LE StAR - M LE StAR SNAP23 -0,6934028 -0,06959534 -1,31721 
M LE StAR - M LE StAR SNAP25 -0,5422028 0,08160466 -1,16601 
M LE StAR - M LE StAR Stx17 -0,7083778 0,007683337 -1,424439 
M LE StAR - M LE StAR NSF a-SNAP SNAP25 -0,7244028 -0,1005954 -1,34821 
M LE StAR - M LE StAR NSF a-SNAP SNAP 23 -0,1986528 0,4251547 -0,8224602 
M LE StAR - M LE StAR NSF a-SNAP -0,4427778 0,1810296 -1,066585 
M LE StAR - M LE StAR SNAP23 SNAP25  -0,6581778 0,05788332 -1,374239 
M LE StAR - M LE StAR NSF a-SNAP SNAP23 SNAP25 -0,8799778 -0,1639166 -1,596039 
M LE StAR SNAREs - M LE StAR SNAP23 0,9132084 1,606532 0,2198852 
M LE StAR SNAREs - M LE StAR SNAP25 1,064408 1,757731 0,3710851 
M LE StAR SNAREs - M LE StAR Stx17 0,8982334 1,675604 0,1208629 
M LE StAR SNAREs - M LE StAR NSF a-SNAP SNAP25 0,8822083 1,575531 0,1888852 
M LE StAR SNAREs - M LE StAR NSF a-SNAP SNAP 23 1,407958 2,101282 0,7146352 
M LE StAR SNAREs - M LE StAR NSF a-SNAP 1,163833 1,857157 0,4705102 
M LE StAR SNAREs - M LE StAR SNAP23 SNAP25  0,9484333 1,725804 0,1710629 
M LE StAR SNAREs –  
M LE StAR NSF a-SNAP SNAP23 SNAP25 0,7266334 1,504004 
-
0,05073708 
M LE StAR SNAP23 –  
M LE StAR NSF a-SNAP SNAP23 SNAP25 -0,186575 0,5452951 -0,9184451 
M LE StAR NSF a-SNAP SNAP25 –  
M LE StAR NSF a-SNAP SNAP23 SNAP25 -0,155575 0,5762951 -0,8874451 
 
Figure 9 A Mean difference between two treatments of group 6 with 95% CI, Sidak's 
multiple comparisons test; B Table showing 95CI for mean differences between two 
treatments of group 6, Sidak’s multiple comparison test  
B 
 
M 
A 
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4.2.5 Effect of adrenal cytosol on pregnenolone  
         concentrations of reconstitution assays (group 3)  
In order to investigate if cytosol of adrenal cells contains further 
components affecting the pregnenolone concentration in reconstitution 
assays, cytosol was extracted and added to different combinations of 
reconstitution assays:  
1)M+LE 
2)M+LE+StAR  
3)M+LE+StAR+SNAREs 
 
A significant difference was found between ln(pregnenolone concentration) 
of:  
 M+LE+StAR+SNAREs vs. M+LE+StAR+SNAREs+cytosol (mean 
difference -0.9564 [CI -1.820 to -0.09301] p<0.05) 
 M+LE+StAR+cytosol vs. M+LE+StAR+SNAREs+cytosl (mean 
difference -1.407 [CI -2.336 to -0.4783] p<0.01) 
 For M+LE+StAR vs. M+LE+StAR+cytosol p=0.0564 (mean difference -
0.9288 [CI -1.875 to> -0.01781] 
In total, the combination of SNAREs and cytosol leads to the highest 
pregnenolone concentration in reconstitution assays so far.  
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Figure 10 A Natural logarithm (ln) of pregnenolone concentrations (ng/ml) of 
reconstitution assays of group 3, M were treated with LE, LE+cytosol, LE+StAR, 
LE+StAR+cytosol, LE+StAR+SNAREs and LE+StAR+SNAREs+cytosol, values are shown 
as mean +/- SD for eleven independent experiments, p<0.001 (**) or p<0.05 (*), 
Sidak’s multiple comparison test B Mean difference between two treatments of group 3 
with 95% CI, Sidak's multiple comparisons test 
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4.2.6 Effect of GTP/GTPγS and adrenal cytosol on  
         pregnenolone concentrations of reconstitution  
         assays (groups 4 and 5)  
Addition of cytosol to reconstitution assays treated with SNAREs has lead 
to a significant increase in pregnenolone concentration. Now it shall be 
investigated if GTP or non-hydrolysable GTPγS show an effect on 
pregnenolone concentration when added to reconstitution assays treated 
with cytosol.  
 
4.2.6.1 Addition of GTP/GTPγS to M+LE+StAR+cytosol  
It was found that GTP added to M+LE+StAR+cytosol leads to a significant 
increase in pregnenolone concentration (p<0.05) while no significant 
difference was found for addition of GTPγS.  
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Figure 11 A Natural logarithm (ln) of pregnenolone concentrations (ng/ml) of 
reconstitution assays of group 4, M were treated with LE+StAR+cytosol, 
LE+StAR+cytosl+GTP and LE+StAR+cytosol+GTPγS, values are shown as mean +/- SD 
for seven independent experiments, p<0.05(*), Dunn’s multiple comparison test  
B Distribution of ranks for the three treatments of group 4, Dunn’s multiple comparison 
test  
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4.2.6.2 Addition of GTP/GTPγS to M+LE+StAR+SNAREs+cytosol 
Addition of GTP or GTPγS to M+LE+StAR+SNAREs+cytosol lead to no 
significant difference in ln(pregnenolone concentration). 
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Figure 12 A Natural logarithm (ln) of pregnenolone concentrations (ng/ml) of 
reconstitution assays of group 5, values are shown as mean +/- SD for six independent 
experiments, no significant difference was found, Tukey’s multiple comparison test;  
B Mean difference between two treatments of group 5 with 95% CI, Sidak's multiple 
comparisons test 
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4.2.7 Effect of BSA and imidazole as negative controls  
         on pregnenolone concentrations of reconstitution  
         assays (group 7 and 8)  
BSA and imidazole were used as negative controls to ensure that a) the 
observed effect of SNAREs is not a mere protein effect leading to 
increased pregnenolone concentrations and b) that increase of 
pregnenolone concentration is not caused by increasing concentrations of 
imidazole, in which the SNAREs are dissolved.  
 
4.2.7.1 Effect of BSA  
It was found that BSA has no effect on the pregnenolone concentration.  
 
****
****
****
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Figure 13 A Pregnenolone concentrations (ng/ml) of reconstitution assays of group 6, M 
were treated with LE, LE+StAR, LE+StAR+SNAREs, LE+BSA, values are shown as mean 
+/- SD for three independent experiments, p<0.001 (***) and p<0.0001 (****), Sidak’s 
multiple comparison test; B Mean difference between two treatments of group 6 95% CI, 
Sidak's multiple comparisons test 
 
4.2.7.2 Effect of imidazole  
Treatment with imidazole showed no significant increase of pregnenolone 
concentration in comparison to M+LE+StAR.  
**
***
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Figure 14 A Pregnenolone concentrations (ng/ml) of reconstitution assays of group 7, M 
were treated with LE+StAR, LE+StAR+SNAREs and LE+StAR+60mM imidazole, values 
are shown as mean +/- SD for three independent experiments, p<0.01 (**) and 
p<0.001 (***), Tukey’s multiple comparison test; B Mean difference between two 
treatments of group 7 with 95% CI, Tukey's multiple comparisons test 
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5 Discussion  
5.1 Intact SNAREs and StAR could be induced,  
      purified and stored in a solute state  
All recombinant proteins could be induced (see Figure 3). In contrast to 
the other induced proteins the band of NSF appears to be weaker on SDS-
PAGE. Recombinant proteins exceeding a size of 80kDa often show a 
varying yield of induction as they are often found to be instable or quickly 
degraded by E.coli proteases.  
Furthermore, all recombinant proteins could be purified (see Figure 4). 
They were eluted with imidazole which keeps the proteins in a solute state 
so that they keep their functional structure. The better the purification of 
the recombinant protein, the less other bands can be seen on the sodium 
dodecyl sulfate -polyacrylamide gel. A sufficient grade of purification was 
reached for all proteins. The fraction containing the highest concentration 
of each recombinant protein, which was indicated by the size of the band, 
was further used. The proteins need to be fully intact to function in the 
reconstitution assay. Except from StAR, none of the recombinant protein 
bands shows signs of partial degradation like double bands or the whole 
band being shifted to a slightly lower molecular size. StAR shows a double 
band increasing with the duration of induction so that it was only induced 
for 2.5 hours maximum.  
 
 
 
5.2 Results of the in-vitro reconstitution assay:  
      Cholesterol is transported from LDs to  
      mitochondria in a SNARE-mediated manner  
5.2.1 Distribution of variances and choice of  
         statistical tests 
It was tested for homoscedasticity to determine which statistical tests will 
be used for evaluating the results (Figure 5). One-way ANOVA requires 
 - 57 - 
homoscedasticity, which was fulfilled by all groups except from group 4. 
For group 4, the heteroscedastic behaviour could possibly be explained by 
the addition of cytosol as the homogeneity of cytosol and the distribution 
of factors within the cytosol affecting the reconstitution assay are hard to 
control. Tukey’s and Sidak’s multiple comparison tests were applied for 
groups 1-3 and 5-8 while Dunn’s multiple comparison test was used for 
group 4 showing a heteroscedastic pattern of variances. 
 
5.2.2 Reconstitution assay with mitochondria isolated  
         from rat ovaries (group 1): Cholesterol is 
         transported from LDs into mitochondria for  
         steroidogenesis and SNAREs are involved in 
         mediating this transportation process 
It has been observed previously that LDs are in physical contact with 
mitochondria (Pu et al., 2011). Furthermore, Shen et al. identified the 
cytoskeletal LD assosicated protein vimentin to be involved in LD 
movement towards mitochondria for steroidogenesis and SNAREs have 
been found on LDs mediating LD fusion (Bostrom et al., 2007; Shen et al., 
2012). However, it has not been investigated yet if LDs transport 
cholesterol to mitochondria for steroidogenesis in a SNARE-mediated 
manner. Within the reconstitution assay, addition of LE or LE+StAR to 
mitochondria isolated from rat ovaries showed no significant difference in 
pregnenolone concentration and hence production. However, addition of 
recombinant SNAREs lead to a significant increase in pregnenolone 
production (p<0.01) (see Figure 6). This indicates that more cholesterol 
has reached the inner mitochondrial membrane for conversion to 
pregnenolone. Hence, cholesterol is transported from LDs into 
mitochondria and the tested SNAREs (SNAP23, SNAP25, NSF, α-SNAP and 
Stx17) are involved in mediating this transportation process.  
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5.2.3 Reconstitution assay with mitochondria isolated  
         from rat adrenals (group 2): SNAREs mediate  
         cholesterol transport from LDs to the outer  
         mitochondrial membrane 
To verify if involvement of SNAREs in cholesterol transport from LDs to 
mitochondria is ovary specific, mitochondria isolated from rat adrenals 
were tested. For adrenal mitochondria, 46 fold increased pregnenolone 
concentrations were found under addition of SNAREs (p<0.0001) 
confirming the results of ovarian mitochondria (see Figure 7).  
Furthermore, a significant difference was discovered between 
mitochondria only and mitochondria under addition of LE and LE+StAR 
(p<0.0001) supporting that cholesterol is transported from LDs to 
mitochondria. The mean difference in pregnenolone concentration was 
bigger for M vs. M+LE+StAR than for M vs. M+LE. This indicates that not 
only the isolated mitochondria but also recombinant StAR are functional. 
Addition of recombinant StAR leads to an increased import of cholesterol 
across the outer mitochondrial membrane within the reconstitution assay. 
Only recently, Rone et al identified the transduceosome/metabolon, a 
dynamic mitochondrial protein complex including i.a. VDAC1, P450scc, 
ATAD3 and TSPO. After initiation by StAR, this complex transports 
cholesterol across the outer mitochondrial membrane, the 
intermembranous space and the inner mitochondrial membrane for 
conversion to pregnenonlone by P450scc (Rone et al., 2012).  
Addition of SNAREs has lead to an even higher pregnenolone production 
demonstrating that in this model transport of cholesterol across the outer 
mitochondrial membrane is not a speed regulating step but depends on 
cholesterol supply from LDs. In vivo, however, StAR-regulated cholesterol 
transport across the outer mitochondrial membrane is the speed 
regulating step of ACTH induced steroidogenesis (Lin et al., 1995; Ohno, 
Yanagibashi, Yonezawa, Ishiwatari, & Matsuba, 1983; Reinhart, Williams, 
& Stocco, 1999). Ohno et al. observed that cholesterol accumulates in the 
outer mitochondrial membrane if corticoidogenic response to ACTH is 
blocked by cycloheximide (Ohno et al., 1983). Furthermore, Stevens et al. 
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identified the outer mitochondrial membrane as location for a 
steroidogenic cholesterol pool which is primarily mobilised by cyclic 
adenosine monophosphate (cAMP)/hormone dependent signals (Stevens, 
Xu, & Lambeth, 1992). This suggests that cholesterol from LDs might 
enter the steroidogenic cholesterol pool of the outer mitochondrial 
membrane from where it could be mobilised by StAR for trespassing 
mitochondrial membranes via the transduceosome/metabolon.  
Different hypotheses address the question how LDs deliver their cargo to 
other organelles. While SNAREs mediate homotypic fusion of LDs, Rab 
proteins (specifically Rab5) regulate the interaction between endosomes 
and LDs as well as ER and LDs (specifically Rab18) (Bostrom et al., 2007; 
P. Liu et al., 2007; Ozeki et al., 2005). However, LDs do not seem to fuse 
with endosomes in vitro as ATP, which is required for SNARE-mediated 
fusion, was found to cause dissociation of bound endosomes from isolated 
LDs (P. Liu et al., 2007). It was proposed that non-fusion interactions may 
lead to formation of transient inter-compartmental contact sites for 
transfer of lipids, ions or small molecules irrespective of ATP-supply 
(Zehmer et al., 2009). In this work, however, ATP was required for in-
vitro SNARE-mediated cholesterol transport from LDs to mitochondria. 
Succinate was added to the reconstitution assay for ATP formation by 
mitochondria and found to be essential for pregnenolone production. 
According to the stalk hypothesis, an intermediate step with formation of 
a stalk between the two membranes precedes total fusion by pore 
formation (Kozlov & Markin, 1983; Kozlovsky, Chernomordik, & Kozlov, 
2002). As LDs are surrounded by a lipid monolayer, stalk formation would 
theoretically lead to access of the cargo (cholesterol) to the outer 
membrane and could hence lead to resupply of cholesterol to the 
steroidogenic cholesterol pool within the outer mitochondrial membrane 
(summary see Figure 15). Overall, the exact mechanism of SNARE-
mediated cholesterol transport to the outer mitochondrial membrane stays 
matter of further investigation.  
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5.2.4 Effect of different combinations of SNAREs on  
         cholesterol transport (group 6): NSF, α-SNAP,  
         SNAP25 and SNAP23 work in a rectified manner on  
         cholesterol transport 
It was shown that the combination of SNAP23, SNAP25, Stx17, NSF and 
α-SNAP influences cholesterol transport from LDs to the outer 
mitochondrial membrane. Different combinations were tested to identify 
which single SNARE or combination of SNAREs accounts for this effect 
(see Figure 8).  
Addition of SNAP23 to M+LE+StAR has lead to a significant increase in 
pregnenolone production (p<0.05) indicating its role in cholesterol 
transport to mitochondria. Previously, SNAP23 was identified to mediate 
LD fusion and insulin stimulated transportation of the glucose transporter 
Glut4 to the plasma membrane (Bostrom et al., 2007; Bostrom et al., 
2005; Kawanishi et al., 2000). Furthermore, Jägerström et al. have 
observed complex formation between LD and mitochondria via confocal 
and electron microscopy. They have found that siRNA knock-down of 
SNAP23 in NIH 3T3 fibroblasts leads to reduced complex formation and 
reduced β-oxidation indicating its role in triacyle glycerine transport from 
LD to mitochondria (Jagerstrom et al., 2009). Interestingly, treatment 
with NSF+α-SNAP+SNAP23 did not lead to a significant increase in 
pregnenolone production but showed lower pregnenolone levels than 
treatment with SNAP23 (p>0.05) which could be explained by NSF and α-
SNAP inducing disassembly of the SNAP23 mediated complex. 
Surprisingly, treatment with NSF+α-SNAP+SNAP25 was followed by 
augmented pregnenolone production (p<0.05) suggesting involvement of 
these SNAREs in cholesterol transport. However, it remains unclear why 
SNAP25 by itself does not cause augmented pregnenolone production and 
why NSF and α-SNAP do not seem to cause disruption of a SNAP25 
comprising complex. NSF, α-SNAP and SNAP25 have all been found on 
LDs but have not been connected with cholesterol transport to 
mitochondria so far (Bostrom et al., 2007).  
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However, even though addition of SNAP 23 and NSF+α-SNAP+SNAP25 
lead to increased pregnenolone production, the rise in pregnenolone 
production is still significantly lower than if all five SNAREs are added 
(p<0.01). In contrast, treatment with NSF+α-SNAP+SNAP25+SNAP23 
resulted in a rise of pregnenolone production equal to the pregnenolone 
increase under addition of all five SNAREs (p=0.08). Hence, it seems likely 
that NSF, α-SNAP, SNAP25 and SNAP23 interact or work in a rectified 
manner on cholesterol transport from LDs to mitochondria. It could be 
assumed that SNAP25 prevents disruption of a SNAP23 comprising LD-
mitochondria complex by NSF and α-SNAP (summary see Figure 15). The 
detailed role of each SNARE within this process, however, remains matter 
of further investigation.  
Interestingly, Stx17 caused an increase in pregnenolone production that 
was close to significance level (p=0.055). Stx17 is abundantly expressed 
in steroidogenic cell types and was found to localize to smooth 
membranes of the ER, which are highly involved in lipid metabolism 
(Steegmaier et al., 2000). Recently, it has been identified to recruit the 
autophagosome marker autophagy related 14 (ATG14) to ER-mitochondria 
contact sites, which seem to be involved in autophagosome formation 
(Hamasaki et al., 2013). ER-mitochondria contact sites also play an 
important role in lipid transport and synthesis suggesting that involvement 
of Stx17 in cholesterol transport is worth further investigation (Rusinol, 
Cui, Chen, & Vance, 1994).  
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Figure 15 Model of SNARE-mediated transport of cholesterol from lipid droplets into 
mitochondria for steroidogenesis 
Cholesterol (C) transport from lipid droplets (LD) to the outer mitochondrial membrane 
(OMM) is influenced by the SNARE-proteins SNAP23 and SNAP25 as well as NSF and α-
SNAP. The role of Stx17 remains to be determined. ATP and cytosol enhance SNARE-
mediated cholesterol transport from LDs to the OMM. C might join pre-existing 
cholesterol pools in the OMM by hemi-fusion between the LD and the OMM or by 
transient intercompartmental contact sites before it is bound by StAR and transferred 
across the OMM, the intermembranous space (IMS) and the inner mitochondrial 
membrane (IMM) into the matrix. C is converted to pregnenolone by P450scc.  
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5.2.5 Effect of adrenal cytosol on cholesterol transport  
         (group 3): Cytosolic components enhance SNARE-  
          mediated cholesterol transport from LDs to  
          mitochondria 
Jägerström et al. have shown that cytosolic factors are involved in the 
formation of complexes between LDs and mitochondria (Jagerstrom et al., 
2009). Similarly, Pu et al. observed that cytosolic factors influence 
physical interaction between mitochondria and LDs (Pu et al., 2011). 
Hence, it was tested if addition of adrenal cytosol has an effect on 
pregnenolone production to investigate if there are further cytosolic 
components notably affecting cholesterol transport from LDs to 
mitochondria.  
A significant increase in pregnenolone production was observed under 
addition of cytosol to reconstitution assays treated with SNAREs (p<0.05) 
but not if it was adjoined to assays without SNAREs (p=0.2696 for M+LE 
vs. M+LE+cytosol and p=0.0564 for M+LE+StAR vs. M+LE+StAR+ 
cytosol) (see Figure 10). This suggests that cytosol might contain 
components that affect SNARE-mediated transport of cholesterol from LDs 
to mitochondria rather than StAR-mediated transport. However, the p-
value of M+LE+StAR vs. M+LE+StAR+cytosol (p=0.0564) is close to 
significance level (0.05). This could be explained by a low level of SNAREs 
naturally present in cytosol. Furthermore, a significant increase in 
ln(pregnenolone concentration) was found between M+LE+StAR+cytosol 
vs. M+LE+StAR+cytosol+SNAREs (p<0.01) which leads to the conclusion 
that SNAREs are essential for cholesterol transport and cannot be replaced 
by cytosolic components (summary see Figure 15).  
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5.2.6 Effect of GTP/GTPγS and adrenal cytosol on  
         cholesterol transport (groups 4 and 5): GTP has no  
         effect on SNARE mediated cholesterol transport  
         from LDs to mitochondria 
It has been observed previously that LD associated Rab proteins regulate 
interaction of LDs with early endosomes (Bartz et al., 2007; P. Liu et al., 
2007; P. Liu et al., 2004). Furthermore, Pu et al. have conducted an in-
vitro reconstitution assay with purified LDs which showed that GTP and 
cytosol affect interaction of LDs with mitochondria indicating that Rab 
proteins might be involved in LD-mitochondria interaction (Pu et al., 
2011). As the results of this work suggest that cytosolic components are 
engaged in SNARE-mediated cholesterol transport from LDs to 
mitochondria, it was investigated if these cytosolic components function 
on GTP, like GTPases or Rab proteins. Therefore, GTP or non-hydrolysable 
GTPγS were added to reconstitution assays.  
It was found that GTP added to M+LE+StAR+cytosol leads to a significant 
increase in pregnenolone production (p<0.05) (see Figure 11). This might 
indicate that cytosolic components require GTP for transport of cholesterol 
to mitochondria. However, addition of GTPγS leads to no significant 
change in pregnenolone production (see Figure 12). As only addition of 
GTP+cytosol to M+LE+StAR but not addition of cytosol (see 5.2.5) or 
cytosol+ GTPγS to M+LE+StAR results in an increased pregnenolone 
production, it seems likely that cytosolic factors can affect cholesterol 
transport to mitochondria in a GTP dependent manner.  
However, addition of GTP or GTPγS to M+LE+StAR+SNAREs+cytosol did 
not lead to any significant change in pregnenolone production suggesting 
that GTP or GTPγS has no influence on SNARE-mediated cholesterol 
transport in this in-vitro assay. It needs to be considered, however, that 
the LDs in this reconstitution assay were artificially produced and not 
isolated from cell extracts as in Pu et al.’s experiments (Pu et al., 2011). 
Hence, they cannot contain any Rab proteins which might be affected by 
GTP/GTPγS so that no conclusion can be drawn about involvement of Rab 
proteins in cholesterol transport from LDs to mitochondria. Overall, it can 
 - 65 - 
be summarised that cytosolic, GTP dependent components can enhance 
cholesterol transport to mitochondria in absence of SNAREs. In presence 
of SNARE components, cytosolic factor augment SNARE-mediated 
cholesterol transport to the outer mitochondrial membrane without need 
for GTP. 
 
5.2.7 Negative controls (group 7 and 8): Neither  
          presence of proteins nor imidazole confound  
          pregnenolone production in the reconstitution  
          assay  
To ensure that the observed effects of SNARE proteins on pregnenolone 
production are not a mere protein effect or caused by imidazole, in which 
the SNAREs and StAR are dissolved and stored, BSA and imidazole served 
as negative controls. 
It was found that neither BSA nor imidazole have an impact on 
pregnenolone concentration (see Figure 13 and Figure 14). They do not 
interfere with the ELISA used for measuring the pregnenolone 
concentrations nor influence the outcome of the reconstitution assay and 
thus, transport of cholesterol to mitochondria. It can be concluded that 
the observed effects of SNARE proteins are truly due to their activity and 
are not caused by a confounder such as mere presence of proteins or 
imidazole.  
 
 
 
5.3 Summary of conclusions  
In this project it was investigated if cholesterol is transported from LDs to 
mitochondria for steroidogenesis in a SNARE-mediated manner. In 
summary, addition of SNARE proteins resulted in a 46fold increase in 
pregnenolone production (p<0.0001, Tukey’s multiple comparison test), 
indicating their involvement in cholesterol transport from lipid droplets to 
mitochondria. In particular, the combination of SNAP23, SNAP25, NSF and 
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α-SNAP was found to mediate cholesterol transport to the outer 
mitochondrial membrane (p<0.05, Sidak’s Multiple Comparison Test) 
while the detailed role of Stx17 remains unclear. Furthermore, it was 
observed that cytosolic components enhance SNARE-mediated cholesterol 
transport without need for GTP (p<0.05, Sidak’s Multiple Comparison 
Test).  
Overall, these results allow proposing a model of SNARE-mediated 
cholesterol transport from lipid droplets to the outer mitochondrial 
membrane and across the mitochondrial membranes into the matrix for 
steroidogenesis. Cholesterol might join the cholesterol pool in the outer 
mitochondrial membrane by hemifusion of lipid droplets with the outer 
mitochondrial membrane. StAR could bind cholesterol from this cholesterol 
pool before it induces its transport across the mitochondrial membranes 
via the transduceosome/metabolon. Cholesterol is then converted into 
pregnenolone as the first step of steroidogenesis in the mitochondrial 
matrix.  
These results raise the question about the exact molecular mechanism of 
SNARE-mediated cholesterol transport to the outer mitochondrial 
membrane and the detailed role of each SNARE within this process. Up to 
now no effect on a known cholesterol transport disease is known. For 
example, siRNA knock-down of Stx17 and SNAP25 would lead to deeper 
insight into their specific roles in cholesterol transport in vivo and 
bimolecular fluorescence complementation assays would allow visualising 
SNARE-complex formation.  
 
  
 
 
 
 
 
 
 
 
A Appendix 
 
 
 
 
 
 
 
 A1 Zusammenfassung  
 
Cholesterinspeicher und -transportstörungen liegen einer Vielzahl von 
Erkrankungen zu Grunde – von der Niemann-Pick Krankheit, über die 
kongenitale Nebennierenhyperplasie bis zur Schaumzellenbildung bei 
Atherosklerose. Eine wichtige Rolle spielt Cholesterin in Nebennieren und 
Ovarien, da es in diesen Organen als Grundbaustein der 
Steroidhormonsynthese dient.  
Intrazelluläres Cholesterin wird in Form von Cholesterinestern in 
Lipidtröpfchen gespeichert. Es muss jedoch in die mitochondriale Matrix 
transportiert werden, um dort als erster Schritt der 
Steroidhormonsynthese in Pregnenolon umgewandelt zu werden. Ein 
Proteinkomplex – das Transduceosome/Metabolon – ist dabei für den 
Transport durch die zwei mitochondrialen Membranen zuständig. Der 
genaue Mechanismus, wie Cholesterin von den Lipidtröpfchen zum 
Transduceosome in der mitochondrialen Außenmembran gelangt, ist 
indessen noch unklar. Da soluble N-ethylmaleimide-sensitive-factor 
attachment receptor-Proteine (SNARE-Proteine), die vesikuläreren 
Transport vermitteln können, auf Lipidtröpfchen gefunden werden, war es 
das Ziel dieser Arbeit zu untersuchen, ob Cholesterin SNARE-vermittelt 
von Lipidtröpfchen zu Mitochondrien transportiert wird.  
 
Dazu wurden Mitochondrien aus Ovarien und Nebennieren von Ratten 
isoliert. In einem in-vitro Assay wurden dann verschiedene Kombinationen 
von rekombinanten, aufgereinigten SNARE-Proteinen (SNAP23, SNAP25, 
NSF, α-SNAP and Stx17) und cholesterinhaltige Lipidtröpfchen zu den 
Mitochondrien hinzu gegeben. Anschließend wurde mittels enzyme linked 
immunosorbent assay (ELISA) gemessen, wie viel Pregnenolon aus dem in 
den Lipidtröpfchen enthaltenen Cholesterin synthetisiert wurde. Zusätzlich 
wurde untersucht, ob GTP und zytosolische Komponenten den 
Cholesterintransport von den Lipidtröpfchen zu den Mitochondrien 
beeinflussen.  
i 
 ii 
In diesem in-vitro Modell erhöhte die Zugabe von SNARE-Proteinen die 
Pregnenolonsynthese um das 46fache (p<0.0001, Tukey’s Multiple 
Comparison Test), welches die Beteiligung von SNARE-Proteinen am 
Cholesterintransport belegt. Die Kombination aus den SNARE-Proteinen 
SNAP23, SNAP25, NSF und α-SNAP ist dabei wesentlich an der 
Vermittlung des Transportprozesses beteiligt (p<0.05, Sidak’s Multiple 
Comparison Test), während die Rolle von Stx17 noch weiterer Aufklärung 
bedarf. Des Weiteren konnte gezeigt werden, dass zytosolische 
Komponenten GTP-unabhängig den SNARE-vermittelten 
Cholesterintransport steigern (p<0.05, Sidak’s Multiple Comparison Test). 
 
Zusammen mit bereits publizierten Daten lassen sich die Ergebnisse zu 
einem Modell zusammenfassen, in dem Cholesterin SNARE-vermittelt von 
Lipidtröpfchen zu Mitochondrien transportiert wird. Dabei könnte das 
Cholesterin durch Hemifusion des Lipidtröpfchens mit der mitochondrialen 
Außenmembran einem Cholesterinpool in der mitochondrialen 
Außenmembran zugeführt werden. An das StAR-Protein (steroidogenesis 
acute regulatory protein) gebunden, welches Teil des Transduceosomes 
ist, würde es anschließend innerhalb der Außenmembran zu dem 
restlichen Transduceosome/Metabolon-Komplex bewegt, welches das 
Cholesterin in die mitochondriale Matrix zur Steroidhormonsynthese 
weitertransportiert.  
 
Diese Arbeit liefert Erkenntnisse über den Transport von Cholesterin von 
Lipidtröpfchen zu Mitochondrien in vitro und vereinigt diese mit dem 
bisherigen Wissensstand in einem Modell über Cholesterintransport von 
Lipidtröpfchen in die mitochondriale Matrix zur Steroidhormonsynthese. 
Dabei bleiben der molekulare Mechanismus des SNARE-vermittelten 
Cholesterintransports und die detaillierte Rolle der einzelnen SNARE-
Proteine in vivo Gegenstand für weitere Forschungsarbeiten. 
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